GB9116133D0 - Amylose granule and its preparation - Google Patents

Amylose granule and its preparation

Info

Publication number
GB9116133D0
GB9116133D0 GB919116133A GB9116133A GB9116133D0 GB 9116133 D0 GB9116133 D0 GB 9116133D0 GB 919116133 A GB919116133 A GB 919116133A GB 9116133 A GB9116133 A GB 9116133A GB 9116133 D0 GB9116133 D0 GB 9116133D0
Authority
GB
United Kingdom
Prior art keywords
amylose
average molecular
molecular weight
granules
granule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB919116133A
Other versions
GB2247242A (en
GB2247242B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hayashibara Seibutsu Kagaku Kenkyujo KK
Original Assignee
Hayashibara Seibutsu Kagaku Kenkyujo KK
Hayashibara Biochemical Laboratories Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hayashibara Seibutsu Kagaku Kenkyujo KK, Hayashibara Biochemical Laboratories Co Ltd filed Critical Hayashibara Seibutsu Kagaku Kenkyujo KK
Publication of GB9116133D0 publication Critical patent/GB9116133D0/en
Publication of GB2247242A publication Critical patent/GB2247242A/en
Application granted granted Critical
Publication of GB2247242B publication Critical patent/GB2247242B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y204/00—Glycosyltransferases (2.4)
    • C12Y204/01—Hexosyltransferases (2.4.1)
    • C12Y204/01019—Cyclomaltodextrin glucanotransferase (2.4.1.19)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A23L29/35—Degradation products of starch, e.g. hydrolysates, dextrins; Enzymatically modified starches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/732—Starch; Amylose; Amylopectin; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/738—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B30/00—Preparation of starch, degraded or non-chemically modified starch, amylose, or amylopectin
    • C08B30/20—Amylose or amylopectin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/16—Preparation of compounds containing saccharide radicals produced by the action of an alpha-1, 6-glucosidase, e.g. amylose, debranched amylopectin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/18—Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Materials Engineering (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

Novel amylose granules advantageously used in the fields of food products, pharmaceuticals and cosmetics exist in an approximately globular-shape of amylose granule or in a conjugation form consisting of two or more of the amylose granules linked together, and having about 2.10 mu m in diameter or major axis, B type form of starch on powder X-ray diffraction analysis, the number-average molecular weight of about 4,000-7,000 on gel permeation chromatography, and the weight- average molecular weight per the number-average molecular weight of about 1.4-1.7. The granules may be prepared by allowing cyclomaltodextrin glucanotransferase (EC 2.4.1.19) to act on an aqueous solution containing a cyclodextrin or starch. In examples the enzyme is derived from Bacillus stearothermophilas or Bacillus macerans; other sources are mentioned. <IMAGE>
GB9116133A 1990-07-26 1991-07-25 Granular amylose and its preparation Expired - Fee Related GB2247242B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2200052A JP2926434B2 (en) 1990-07-26 1990-07-26 Amylose particles and method for producing the same

Publications (3)

Publication Number Publication Date
GB9116133D0 true GB9116133D0 (en) 1991-09-11
GB2247242A GB2247242A (en) 1992-02-26
GB2247242B GB2247242B (en) 1994-04-06

Family

ID=16418031

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9116133A Expired - Fee Related GB2247242B (en) 1990-07-26 1991-07-25 Granular amylose and its preparation

Country Status (2)

Country Link
JP (1) JP2926434B2 (en)
GB (1) GB2247242B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113678933A (en) * 2021-08-10 2021-11-23 江南大学 Method for enhancing gel property of starch soft sweets by enzyme method and application thereof
CN118141943A (en) * 2024-03-14 2024-06-07 上海市第十人民医院 Starch iodine nanomaterial and preparation method and application thereof

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5368878A (en) 1990-02-20 1994-11-29 A. E. Staley Manufacturing Company Reduced fat meat products
US5387426A (en) 1990-02-20 1995-02-07 A.E. Staley Manufacturing Company Method of preparing reduced fat foods
US5372835A (en) 1990-02-20 1994-12-13 A. E. Staley Manufacturing Company Method of preparing reduced fat foods
AU652743B2 (en) 1990-02-20 1994-09-08 A.E. Staley Manufacturing Company Hydrolysed starch as a substitute for fat in food
US5395640A (en) 1990-02-20 1995-03-07 A.E. Staley Manufacturing Company Method of preparing reduced fat foods
US5378491A (en) 1990-02-20 1995-01-03 A. E. Staley Manufacturing Co. Method of preparing a starch hydrolysate, an aqueous starch hydrolysate dispersion, method of preparing a food containing a starch hydrolysate, and a food formulation containing a starch hydrolysate
US5409726A (en) 1990-02-20 1995-04-25 A. E. Staley Manufacturing Co. Method of preparing reduced fat foods
US5374442A (en) 1990-02-20 1994-12-20 A. E. Staley Manufacturing Company Method of preparing reduced fat foods
US5436019A (en) 1990-02-20 1995-07-25 A. E. Staley Manufacturing Co. Method of preparing reduced fat foods
US5376399A (en) 1992-05-15 1994-12-27 A.E. Staley Manufacturing Co. Reduced fat cremes
USH1394H (en) 1992-05-22 1995-01-03 A. E. Staley Manufacturing Company Method of preparing reduced fat spreads
USH1395H (en) 1992-05-22 1995-01-03 A. E. Staley Manufacturing Company Composition and method of preparing reduced fat spreads
NL9300131A (en) * 1993-01-22 1994-08-16 Avebe Coop Verkoop Prod Method for fractionating starch.
FR2716199B1 (en) * 1994-02-15 1996-04-26 Roquette Freres Process for the manufacture of a starch hydrolyzate with a low polymolecularity index, a new starch hydrolyzate thus obtained and its use in peritoneal dialysis.
DE19737481A1 (en) * 1997-08-28 1999-03-04 Hoechst Ag Microparticles containing spherical linear polysaccharides
DE19839216C1 (en) * 1998-08-28 2000-01-20 Aventis Res & Tech Gmbh & Co Preparation of biocompatible, biodegradable water-insoluble polysaccharide microparticles, used e.g. as fillers for polymers or in diagnostic tests
DE19860371A1 (en) * 1998-12-28 2000-06-29 Aventis Res & Tech Gmbh & Co Cosmetic or medical preparation for topical use
AU752746B2 (en) * 1998-12-28 2002-09-26 Celanese Ventures Gmbh Sun protection product with microparticles on the basis of water-insoluble linear polyglucan
DE19860373B4 (en) * 1998-12-28 2004-02-19 Celanese Ventures Gmbh Oral care products and use of spherical microparticles
DE19902917C2 (en) * 1999-01-26 2001-03-29 Aventis Res & Tech Gmbh & Co Water-insoluble linear polysaccharides for filtration
US20080286410A1 (en) * 2007-03-06 2008-11-20 Richmond Patricia A Production of Resistant Starch Product
EP2685991A1 (en) * 2011-03-18 2014-01-22 Baxter International Inc Peritoneal dialysis solutions comprising glucose polymers
JP7354237B2 (en) 2019-05-13 2023-10-02 昭和産業株式会社 Modifiers, modification compositions containing the modifiers, foods and drinks, pharmaceuticals, cosmetics, industrial products, feeds, culture media, or fertilizers using these, and methods for modifying these products

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4587332A (en) * 1984-02-28 1986-05-06 Ogilvie Mills Ltd. Modified wheat "B" starch for corrugating adhesives
US4551177A (en) * 1984-04-23 1985-11-05 National Starch And Chemical Corporation Compressible starches as binders for tablets or capsules

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113678933A (en) * 2021-08-10 2021-11-23 江南大学 Method for enhancing gel property of starch soft sweets by enzyme method and application thereof
CN118141943A (en) * 2024-03-14 2024-06-07 上海市第十人民医院 Starch iodine nanomaterial and preparation method and application thereof

Also Published As

Publication number Publication date
JPH0485301A (en) 1992-03-18
GB2247242A (en) 1992-02-26
JP2926434B2 (en) 1999-07-28
GB2247242B (en) 1994-04-06

Similar Documents

Publication Publication Date Title
GB2247242B (en) Granular amylose and its preparation
Koga et al. Sucrose-dependent cell adherence and cariogenicity of serotype c Streptococcus mutans
Gibbons et al. Strains of Streptococcus mutans and Streptococcus sobrinus attach to different pellicle receptors
AU5741286A (en) Conjugate constituted from a wall adhesin of s.mutans of proteinic nature and from a polysaccharide of s.mutans, its preparation and its use particularly in anti-caries vaccines
AU628712B2 (en) Graft copolymers of monosaccharides, oligosaccharides, polysaccharides and modified polysaccharides, the preparation thereof, and their use
CA2151438A1 (en) Thermostable trehalose-releasing enzyme, and its preparation and uses
TW345592B (en) Adhesive compositions
IL98604A0 (en) Mixtures of low molecular weight polysaccharides,their preparation and pharmaceutical compositions containing them
PT1944033E (en) Use of pectin hydrolysis products
IL105160A (en) Pseudomonas exotoxin, its preparation and pharmaceutical compositions containing it
NZ234362A (en) Polymer base-blend compositions containing destructurised starch and cationically modified polysaccharide
IL56309A (en) Inclusion complex of cyclodextrin and indomethacin,its preparation and pharmaceutical compositions containing them
CA2305981A1 (en) Dough compositions made with dehydrated potato flanules
Hamada et al. Interaction of glucosyltransferase from Streptococcus mutans with various glucans
BG104534A (en) Fluidized polymer suspensions of cationic polysaccharides in emollients and use thereof in preparing personal care compositions
NO985094D0 (en) Polymer powder which is redispersible in aqueous solutions
PL336000A1 (en) Cosmetic compositions containing a cationic polymer of low molecular weight and a silicone as well as their application
Koga et al. Role of primers in glucan synthesis by glucosyltransferases from Streptococcus mutans strain OMZ176
AU4618989A (en) 2-iminobenzothiazoline derivatives, their preparation and pharmaceutical compositions containing them
EP0758658A3 (en) Redispersible polymer and production process thereof
Trautner et al. Structure of extracellular glucans synthesized by Streptococcus mutans of serotypes a–e in vitro
RU97105044A (en) STRAIN BIFIDOBACTERIUM ADOLESCENTIS G17513 USED FOR OBTAINING BIPHIDO-CONTAINING EUBiotics AND MEDICINAL FOOD
KR930021206A (en) Cytarabine Oxphosphate Hard Capsule
AU638082B2 (en) Thiazolyl-5-carbonamide derivatives, the preparation thereof composition containing them and their use against microorganisms
Trautner et al. Extracellular polysaccharide synthesized by the oral bacterium Streptococcus mutans of serotype a to ein vitro

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20000725